Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
61.10
-0.10 (-0.16%)
Apr 28, 2026, 1:30 PM CST
6.82%
Market Cap 10.92B
Revenue (ttm) 7.02B
Net Income (ttm) 927.66M
Shares Out 178.70M
EPS (ttm) 5.18
PE Ratio 11.80
Forward PE n/a
Dividend 2.00 (3.27%)
Ex-Dividend Date Aug 6, 2025
Volume 128,013
Average Volume 304,752
Open 61.20
Previous Close 61.20
Day's Range 61.00 - 61.30
52-Week Range 53.50 - 66.60
Beta 0.07
RSI 35.95
Earnings Date May 7, 2026

About TPE:1720

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company o... [Read more]

Sector Healthcare
Founded 1967
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1720
Full Company Profile

Financial Performance

In 2025, TPE:1720's revenue was 7.02 billion, an increase of 3.44% compared to the previous year's 6.79 billion. Earnings were 927.66 million, an increase of 5.36%.

Financial Statements

News

There is no news available yet.